HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

John T Schiller Selected Research

heparitinsulfate lyase

12/2009The initial steps leading to papillomavirus infection occur on the basement membrane prior to cell surface binding.
3/2009Role of heparan sulfate in attachment to and infection of the murine female genital tract by human papillomavirus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


John T Schiller Research Topics

Disease

64Infections
03/2022 - 03/2003
37Papillomavirus Infections
01/2022 - 07/2003
35Neoplasms (Cancer)
01/2022 - 07/2003
26Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2022 - 07/2003
10Uterine Cervical Dysplasia
01/2022 - 08/2006
7Persistent Infection
01/2022 - 05/2006
4Papilloma (Papillomatosis)
01/2020 - 12/2013
4Condylomata Acuminata (Genital Wart)
06/2013 - 05/2006
3Sexually Transmitted Diseases (Sexually Transmitted Disease)
01/2019 - 12/2009
2Virus Diseases (Viral Diseases)
05/2011 - 09/2010
2Wounds and Injuries (Trauma)
06/2010 - 12/2009
1COVID-19
01/2022
1Uveal melanoma
01/2018
1Non-Muscle Invasive Bladder Neoplasms
07/2016
1Noncommunicable Diseases
04/2016
1Hypersensitivity (Allergy)
04/2016
1Malaria
04/2016
1Lung Neoplasms (Lung Cancer)
02/2016
1Spontaneous Abortion (Miscarriage)
09/2015
1Measles
05/2015
1Typhoid Fever (Typhoid)
05/2015
1Warts (Wart)
06/2014
1Oropharyngeal Neoplasms
01/2013
1Vesicular Stomatitis
01/2012
1Reinfection
06/2009
1Carcinoma (Carcinomatosis)
05/2009
1Vulvovaginal Candidiasis
08/2008
1Genetic Predisposition to Disease (Genetic Predisposition)
04/2008

Drug/Important Bio-Agent (IBA)

61VaccinesIBA
03/2022 - 07/2003
17Papillomavirus Vaccines (HPV Vaccines)IBA
01/2022 - 04/2004
14AntibodiesIBA
01/2021 - 07/2003
13DNA (Deoxyribonucleic Acid)IBA
01/2022 - 05/2004
10Proteins (Proteins, Gene)FDA Link
01/2017 - 07/2003
7Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA
01/2022 - 12/2008
7Capsid Proteins (Capsid Protein)IBA
01/2017 - 07/2003
7Neutralizing AntibodiesIBA
12/2012 - 07/2003
5AntigensIBA
01/2018 - 07/2003
4Peptides (Polypeptides)IBA
01/2022 - 04/2004
4Combined VaccinesIBA
01/2022 - 12/2014
4CarrageenanIBA
02/2016 - 07/2006
418 L1 type 16 human papillomavirus vaccine (Cervarix)IBA
06/2014 - 08/2008
4FurinIBA
06/2010 - 01/2006
3EpitopesIBA
01/2022 - 05/2008
3Pharmaceutical PreparationsIBA
01/2021 - 01/2012
3Antiviral Agents (Antivirals)IBA
01/2021 - 09/2006
3Heparin (Liquaemin)FDA LinkGeneric
01/2018 - 03/2009
318 16 11 Types 6 Human Papillomavirus Recombinant Vaccine Quadrivalent (Gardasil)FDA Link
06/2014 - 08/2008
3Heparitin Sulfate (Heparan Sulfate)IBA
03/2009 - 07/2006
2Small Interfering RNA (siRNA)IBA
01/2022 - 01/2012
2Neoplasm Antigens (Tumor Antigens)IBA
01/2022 - 01/2018
2Adenosine Triphosphate (ATP)IBA
01/2021 - 10/2011
2Viral DNAIBA
01/2019 - 08/2007
2Oncogene Proteins (Oncogene Protein)IBA
01/2018 - 04/2008
2LuciferasesIBA
06/2014 - 11/2012
2Cell Surface ReceptorsIBA
06/2010 - 12/2008
2heparitinsulfate lyaseIBA
12/2009 - 03/2009
2Polysaccharides (Glycans)IBA
07/2007 - 07/2006
2Immunoglobulin G (IgG)IBA
05/2005 - 04/2004
1Poly CIBA
01/2022
1T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
01/2022
1Chondroitin Sulfates (Chondroitin Sulfate)IBA
01/2022
1AcidsIBA
01/2022
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2022
1Chondroitin Sulfate ProteoglycansIBA
01/2022
1Immune Checkpoint InhibitorsIBA
01/2021
1CalreticulinIBA
01/2021
1Coloring Agents (Dyes)IBA
01/2018
1Interferon-gamma (Interferon, gamma)IBA
01/2017
1CytokinesIBA
01/2017
1ProdrugsIBA
07/2016
1Thymidine KinaseIBA
07/2016
1Ganciclovir (Cytovene)FDA LinkGeneric
07/2016
1AutoantigensIBA
04/2016
1Indicators and Reagents (Reagents)IBA
02/2016
1Virus-Like Particle VaccinesIBA
01/2016
1Hepatitis A Vaccines (Hepatitis A Vaccine)IBA
09/2015
1Attenuated VaccinesIBA
05/2015
1CarcinogensIBA
08/2014
1Cyclosporine (Ciclosporin)FDA LinkGeneric
08/2014
1FlagellinIBA
06/2014
1LigandsIBA
06/2014
1Complement System Proteins (Complement)IBA
01/2012
1Biological ProductsIBA
01/2012
1phenylmercury borateIBA
05/2011
1Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA
12/2009
1Proprotein Convertase 5IBA
12/2009
1aluminum sulfate (alum)IBA
06/2009
11018 oligonucleotideIBA
06/2009
1Phosphates (Orthophosphate)IBA
06/2009
1GPI0100IBA
06/2009
1Peptide Hydrolases (Proteases)FDA Link
12/2008
1Amphotericin B (Amphotericin)FDA LinkGeneric
08/2008
1AzolesIBA
08/2008
1BasantIBA
08/2008

Therapy/Procedure

4Therapeutics
01/2022 - 08/2007
3Immunotherapy
01/2022 - 07/2016
2Intravenous Injections
01/2021 - 02/2016
2Aftercare (After-Treatment)
01/2021 - 01/2016
2Secondary Prevention
10/2008 - 08/2006
1Intramuscular Injections
06/2010